Hormel Foods Corporation has announced a definitive agreement to sell its whole-bird turkey business to Life-Science Innovations (LSI). The transaction, expected to close by the end of the second quarter of fiscal 2026, marks a significant strategic pivot for the food giant as it seeks to reduce exposure to commodity market volatility.
The deal sees Hormel offloading the upstream and commodity-heavy segments of its turkey operations while retaining the high-margin, value-added components of its portfolio—specifically the JENNIE-O® brand.
The divestment aligns with Hormel’s long-term strategy to shift its revenue mix away from commodity-driven businesses, which are susceptible to grain prices and avian flu fluctuations, towards more stable, branded protein solutions.
Jeff Ettinger, interim Chief Executive Officer of Hormel Foods, explained the decision:
"Our strategy for sustainable, profitable growth centres on expanding our value-added protein portfolio to meet evolving consumer needs, while reducing our exposure to more volatile, commodity-driven businesses."
Asset Transfer and Operational Continuity
Under the terms of the agreement, LSI will acquire significant physical assets in Minnesota, including:
Production: The whole-bird production facility in Melrose, MN.
Supply Chain: The feed mill in Swanville, MN, and associated transportation assets.
Grower Network: Supply contracts with third-party turkey growers dedicated to the whole-bird business.
To ensure an uninterrupted supply for customers, the two companies have structured a transitional period. LSI will provide co-manufacturing services to Hormel Foods through the end of fiscal 2026.
JENNIE-O® Stays with Hormel
Crucially for retailers and consumers, the transaction does not include the JENNIE-O® brand name or its broader array of value-added products (such as ground turkey, burgers, and deli meats).
John Ghingo, President of Hormel Foods, noted that the move allows for a "more focused turkey portfolio," enabling the company to double down on the branded, processed segments of the category.
Buyer Perspective
For Life-Science Innovations, the acquisition represents a consolidation of its supply chain capabilities. Richard Huisinga, CEO of LSI, described the deal as a continuation of a "75-year relationship" with the Jennie-O business, combining Hormel’s assets with LSI’s existing hatchery and grower infrastructure.
Financial terms were not disclosed, though Hormel expects the sale to have a "minimal impact" on its adjusted fiscal 2026 financial results.
.png)
